Therefore, the insufficiency of miR-124-3p inversely correlated with CRKL upregulation might contribute to HCC clinical progression via elevated malignancy of HCC cancer cells through C-JUN, BAX, and BCL-2 deregulations. The gene discussed is BCL2; the disease is hepatocellular carcinoma.